![](https://investorshub.advfn.com/uicon/564105.png?cb=1547105359)
Thursday, March 21, 2019 11:22:57 AM
Just ran into this:
https://www.medtechy.com/articles/2019/medtronic-ceo-provides-update-on-robotic-surgery-program
In 2016, they (MDT) said they planned to roll it out in India first and hoped to be generating revenue with it in the US by end of 2019. With the slip of about a year that they announced last February(-ish) that pushes them out to 2020, and this article seems to question if they will hit that target. The upshot is that it would appear Medtronic won't have any sort of market foothold when Titan launches, and Mr. McNally recently said they now want to roll out on the East Coast (US) first.
I am more concerned about Medrobotics; their current focus appears to be "trans-orifice" at the moment but I assume it could adapt easily to an abdominal port.
And with JnJ, one never knows what they are hiding! But if the combined IP of ISRG and Mr. Brar's program can hold off single-port competition, it will be a huge score for us.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM